267 related articles for article (PubMed ID: 24897108)
61. Genetic alterations in intrahepatic cholangiocarcinoma as revealed by degenerate oligonucleotide primed PCR-comparative genomic hybridization.
Lee JY; Park YN; Uhm KO; Park SY; Park SH
J Korean Med Sci; 2004 Oct; 19(5):682-7. PubMed ID: 15483344
[TBL] [Abstract][Full Text] [Related]
62. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
[TBL] [Abstract][Full Text] [Related]
63. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
64. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
65. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
[TBL] [Abstract][Full Text] [Related]
66. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation.
Chuensumran U; Saelee P; Punyarit P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382
[TBL] [Abstract][Full Text] [Related]
67. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
[TBL] [Abstract][Full Text] [Related]
68. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.
Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC
Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888
[TBL] [Abstract][Full Text] [Related]
69. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis.
Long J; Huang S; Bai Y; Mao J; Wang A; Lin Y; Yang X; Wang D; Lin J; Bian J; Yang X; Sang X; Wang X; Zhao H
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33051665
[TBL] [Abstract][Full Text] [Related]
70. Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis.
Shen Z; Cai J; Tao L; Zheng J; Ye Z; Liu Y; Pan H; Wang Y; Xu J; Liang X
Cancer Gene Ther; 2023 Dec; 30(12):1663-1678. PubMed ID: 37828105
[TBL] [Abstract][Full Text] [Related]
71. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
Jinawath N; Chamgramol Y; Furukawa Y; Obama K; Tsunoda T; Sripa B; Pairojkul C; Nakamura Y
Hepatology; 2006 Oct; 44(4):1025-38. PubMed ID: 17006947
[TBL] [Abstract][Full Text] [Related]
72. The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Sugiura K; Mishima T; Takano S; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takada M; Miyazaki M; Ohtsuka M
Am J Pathol; 2019 Sep; 189(9):1863-1877. PubMed ID: 31220448
[TBL] [Abstract][Full Text] [Related]
73. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
Zhu AX; Borger DR; Kim Y; Cosgrove D; Ejaz A; Alexandrescu S; Groeschl RT; Deshpande V; Lindberg JM; Ferrone C; Sempoux C; Yau T; Poon R; Popescu I; Bauer TW; Gamblin TC; Gigot JF; Anders RA; Pawlik TM
Ann Surg Oncol; 2014 Nov; 21(12):3827-34. PubMed ID: 24889489
[TBL] [Abstract][Full Text] [Related]
74. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Koo SH; Ihm CH; Kwon KC; Park JW; Kim JM; Kong G
Cancer Genet Cytogenet; 2001 Oct; 130(1):22-8. PubMed ID: 11672769
[TBL] [Abstract][Full Text] [Related]
75. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
Lee KT; Liu TS
World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
[TBL] [Abstract][Full Text] [Related]
76. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
77. Expression of DPC4/Smad4 gene in stone-containing intrahepatic bile duct.
Lee KT; Chang WT; Wang SN; Chuang SC; Chai CY; Hu SW
J Surg Oncol; 2006 Sep; 94(4):338-43. PubMed ID: 16917866
[TBL] [Abstract][Full Text] [Related]
78. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
79. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
80. Hierarchical structure and modules in the Escherichia coli transcriptional regulatory network revealed by a new top-down approach.
Ma HW; Buer J; Zeng AP
BMC Bioinformatics; 2004 Dec; 5():199. PubMed ID: 15603590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]